Human parvovirus B19: A new emerging pathogen of inflammatory cardiomyopathy

Journal of Veterinary Medicine Series B: Infectious Diseases and Veterinary Public Health

Volumn 52, Issue 7-8, 2005, Pages 340-343

  Bock, C T ^a   Klingel, K ^a   Aberle, S ^a   Duechting, A ^a   Lupescu, A ^a   Lang, F ^a   Kandolf, R ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENTEROVIRUS; ERYTHROVIRUS; PARVOVIRUS;

CONGESTIVE CARDIOMYOPATHY; HUMAN; PARVOVIRUS; PATHOGENICITY; REVIEW; VIROLOGY; VIRUS INFECTION;

CARDIOMYOPATHY, DILATED; HUMANS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN;

EID: 33644696425     PISSN: 09311793     EISSN: 14390450     Source Type: Journal    
DOI: 10.1111/j.1439-0450.2005.00867.x     Document Type: Conference Paper

References (41)

1. Anderson, M. J., P. G. Higgins, L. R. Davis, J. S. Willman, S. E. Jones, I. M. Kidd, J. R. Pattison, and D. A. Tyrrell, 1985: Experimental parvoviral infection in humans. J. Infect. Dis. 152, 257-265.
2. Barah, F., P. J. Vallely, M. L. Chiswick, G. M. Cleator, and J. R. Kerr, 2001: Association of human parvovirus B19 infection with acute meningoencephalitis. Lancet 358, 729-730.
3. Brown, K. E., S. M. Anderson, and N. S. Young, 1993: Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262, 114-117.
4. Brown, K. E., N. S. Young, and J. M. Liu, 1994: Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit. Rev. Oncol. Hematol. 16, 1-31.
5. Bültmann, B. D., K. Klingel, K. Sotlar, C. T. Bock, H. A. Baba, M. Sauter, and R. Kandolf, 2003a: Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum. Pathol. 34, 92-95.
6. Bültmann, B. D., K. Klingel, K. Sotlar, C. T. Bock, and R. Kandolf, 2003b: Parvovirus B19: a pathogen responsible for more than hematologic disorders. Virchows Arch. 442, 8-17.
7. Cossart, Y. E., A. K. Field, B. Cant, and D. Widdows, 1975: Parvovirus-like particles in human sera. Lancet 1 (7898), 72-73.
8. Cotmore, S. F., V. C. McKie, L. J. Anderson, C. R. Astell, and P. Tattersall, 1986: Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J. Virol. 60, 548-557.
9. Dingli, D., D. H. Pfizenmaier, E. Arromdee, P. Wennberg, P. C. Spittell, A. Chang-Miller, and B. L. Clarke, 2000: Severe digital arterial occlusive disease and acute parvovirus B19 infection. Lancet 356, 312-314.
10. Doerig, C., P. Beard, and B. Hirt, 1987: A transcriptional promoter of the human parvovirus B19 active in vitro and in vivo. Virology 157, 539-542.
11. Dorsch, S., G. Liebisch, B. Kaufmann, P. von Landenberg, J. H. Hoffmann, W. Drobnik, and S. Modrow, 2002: The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J. Virol. 76, 2014-2018.
12. Drago, F., M. Semino, P. Rampini, and A. Rebora, 1999: Parvovirus B19 infection associated with acute hepatitis and a purpuric exanthem. Br. J. Dermatol. 141, 160-161.
13. Finkel, T. H., T. J. Torok, P. J. Ferguson, E. L. Durigon, S. R. Zaki, D. Y. Leung, R. J. Harbeck, E. W. Gelfand, F. T. Saulsbury, and J. R. Hollister, 1994: Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 343, 1255-1258.
14. Heegaard, E. D., and K. E. Brown, 2002: Human parvovirus B19. Clin. Microbiol. Rev. 15, 485-505.
15. Hemauer, A., A. von Poblotzki, A. Gigler, P. Cassinotti, G. Siegl, H. Wolf, and S. Modrow, 1996: Sequence variability among different parvovirus B19 isolates. J. Gen. Virol. 77, 1781-1785.
16. Hicks, K. E., R. C. Cubel, B. J. Cohen, and J. P. Clewley, 1996: Sequence analysis of a parvovirus B19 isolate and baculovirus expression of the non-structural protein. Arch. Virol. 141, 1319-1327.
17. Hokynar, K., M. Soderlund-Venermo, M. Pesonen, A. Ranki, O. Kiviluoto, E. K. Partio, and K. Hedman, 2002: A new parvovirus genotype persistent in human skin. Virology 302, 224-228.
18. Hsu, T. C., W. J. Wu, M. C. Chen, and G. J. Tsay, 2004: Human parvovirus B19 non-structural protein (NS1) induces apoptosis through mitochondria cell death pathway in COS-7 cells. Scand. J. Infect. Dis. 36, 570-577.
19. Kandolf, R., 2004: Virus etiology of inflammatory cardiomyopathy. Dtsch. Med. Wochenschr. 129, 2187-2192.
20. Karetnyi, Y. V., P. R. Beck, R. S. Markin, A. N. Langnas, and S. J. Naides, 1999: Human parvovirus B19 infection in acute fulminant liver failure. Arch. Virol. 144, 1713-1724.
21. Klingel, K., M. Sauter, C. T. Bock, G. Szalay, J. J. Schnorr, and R. Kandolf, 2004: Molecular pathology of inflammatory cardiomyopathy. Med. Microbiol. Immunol. 193, 101-107.
22. Kühl, U., M. Pauschinger, T. Bock, K. Klingel, C. P. Schwimmbeck, B. Seeberg, L. Krautwurm, W. Poller, H. P. Schultheiss, and R. Kandolf, 2003: Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 108, 945-950.
23. Liu, J. M., S. W. Green, T. Shimada, and N. S. Young, 1992: A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus. J. Virol. 66, 4686-4692.
24. Luo, W., and C. R. Astell, 1993: A novel protein encoded by small RNAs of parvovirus B19. Virology 195, 448-455.
25. Malm, C., E. Fridell, and K. Jansson, 1993: Heart failure after parvovirus B19 infection. Lancet 341, 1408-1409.
26. Mitchell, L. A., 2002: Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infections? J. Med. Virol. 67, 267-274.
27. Moffatt, S., N. Yaegashi, K. Tada, N. Tanaka, and K. Sugamura, 1998: Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J. Virol. 72, 3018-3028.
28. Moore, T. L., 2000: Parvovirus-associated arthritis. Curr. Opin. Rheumatol. 12, 289-294.
29. Morinet, F., 1992: Parvovirus B19 infection. Pathol. Biol. (Paris) 40, 621-622.
30. Murry, C. E., K. R. Jerome, and D. D. Reichenbach, 2001: Fatal parvovirus myocarditis in a 5-year-old girl. Hum. Pathol. 32, 342-345.
31. Nguyen, Q. T., C. Sifer, V. Schneider, X. Allaume, A. Servant, F. Bernaudin, V. Auguste, and A. Garbarg-Chenon, 1999: Novel human erythrovirus associated with transient aplastic anemia. J. Clin. Microbiol. 37, 2483-2487.
32. Nigro, G., V. Bastianon, V. Colloridi, F. Ventriglia, P. Gallo, G. D'Amati, W. C. Koch, and S. P. Adler, 2000: Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin. Infect. Dis. 31, 65-69.
33. Pattison, J. R., 1987: B19 virus - a pathogenic human parvovirus. Blood Rev. 1, 58-64.
34. Schowengerdt, K. O., J. Ni, S. W. Denfield, R. J. Gajarski, N. E. Bowles, G. Rosenthal, D. L. Kearney, J. K. Price, B. B. Rogers, G. M. Schauer, R. E. Chinnock, and J. A. Towbin, 1997: Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation 96, 3549-3554.
35. Sol, N., J. J. Le, I. Vassias, J. M. Freyssinier, A. Thomas, A. F. Prigent, B. B. Rudkin, S. Fichelson, and F. Morinet, 1999: Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J. Virol. 73, 8762-8770.
36. Tschöpe, C., C. T. Bock, M. Kasner, M. Noutsias, D. Westermann, P. L. Schwimmbeck, M. Pauschinger, W. C. Poller, R. Kandolf, U. Kuehl, and H. P. Schultheiss, 2005: High prevalence of cardiac Parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111, 879-886.
37. Weigel-Kelley, K. A., M. C. Yoder, and A. Srivastava, 2001: Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells. J. Virol. 75, 4110-4116.
38. Weigel-Kelley, K. A., M. C. Yoder, and A. Srivastava, 2003: Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 102, 3927-3933.
39. Yoto, Y., T. Kudoh, H. Asanuma, K. Numazaki, Y. Tsutsumi, S. Nakata, and S. Chiba, 1994: Transient disturbance of consciousness and hepatic dysfunction associated with human parvovirus B19 infection. Lancet 344, 624-625.
40. Yoto, Y., T. Kudoh, K. Haseyama, N. Suzuki, and S. Chiba, 1996: Human parvovirus B19 infection associated with acute hepatitis. Lancet 347, 868-869.
41. Zhi, N., Z. Zadori, K. E. Brown, and P. Tijssen, 2004: Construction and sequencing of an infectious clone of the human parvovirus B19. Virology 318, 142-152.